Respiratory Disease Vaccine Market Size and Growth 2035
According to market projections, the global respiratory disease vaccine market, valued at USD 65.72 billion in 2025, is anticipated to reach USD 98.41 billion by 2035, growing at a CAGR of 4.12% over the next decade. The rising prevalence of respiratory diseases and advances in vaccine technology drive the respiratory disease vaccine market. North America dominated the global market due to a robust healthcare infrastructure and strong procurement budgets.
Last Updated : 21 August 2026
Category: Therapeutic Area
Insight Code: 6441
Format: PDF / PPT / Excel